Showing results (121-130 of 212) with videos related to
Sort By:
Pageof 22
ACS Central Science|November 3, 2021
In Vivo Measurement of Granzyme Proteolysis from Activated Immune Cells with PETNing Zhao, Conner Bardine, André Luiz Lourenço, et al.Nature Communications|March 2, 2025
Dissecting tumor cell programs through group biology estimation in clinical single-cell transcriptomicsShreya Johri, Kevin Bi, Breanna M Titchen, et al.NPJ Breast Cancer|November 21, 2025
Phase Ib study of intratumoral talimogene laherparepvec (T-VEC) in combination with chemotherapy or endocrine therapy in patients with advanced HER2-negative breast cancerLaura A Huppert, Amelia S Gliwa, Madeline Tait, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 17, 2022
A Phase Ib/II Study of the CDK4/6 Inhibitor Ribociclib in Combination with Docetaxel plus Prednisone in Metastatic Castration-Resistant Prostate CancerIvan de Kouchkovsky, Arpit Rao, Benedito A Carneiro, et al.Cancer Immunology Research|December 20, 2019
Intratumoral Plasmid IL12 Electroporation Therapy in Patients with Advanced Melanoma Induces Systemic and Intratumoral T-cell ResponsesSamantha K Greaney, Alain P Algazi, Katy K Tsai, et al.Journal of the National Cancer Institute|September 27, 2014
Activated lymphocyte recruitment into the tumor microenvironment following preoperative sipuleucel-T for localized prostate cancerLawrence Fong, Peter Carroll, Vivian Weinberg, et al.Transplantation|October 28, 2010
Islet transplantation in type 1 diabetic patients using calcineurin inhibitor-free immunosuppressive protocols based on T-cell adhesion or costimulation blockadeAndrew M Posselt, Gregory L Szot, Lynda A Frassetto, et al.Science Advances|October 8, 2025
Combination LIGHT overexpression and checkpoint blockade disrupts the tumor immune environment impacting colorectal liver metastasesBridget P Keenan, Guilin Qiao, Nicholas Kunda, et al.Clinical Genitourinary Cancer|October 18, 2018
Itraconazole as a Noncastrating Treatment for Biochemically Recurrent Prostate Cancer: A Phase 2 StudyMina Lee, Haemin Hong, Won Kim, et al.Cell Reports|June 14, 2018
Targeting EZH2 Reprograms Intratumoral Regulatory T Cells to Enhance Cancer ImmunityDavid Wang, Jason Quiros, Kelly Mahuron, et al.Pageof 22